| Plénière I: |
Progress in Cancer Treatment: Molecular Targets |
|
Lionel D. Lewis |
|
Dartmouth Medical School & Dartmouth-Hitchcock Medical Center, Lebanon, USA
|
|
|
| Plénière II: |
Nanomedicines: Entering the Mainstream |
|
Theresa M. Allen |
|
University of Alberta, Edmonton, Canada
|
|
|
| Plénière III: |
Innovations in the Treatment of Dyslipemias |
|
Jacques Genest |
|
McGill University Health Centre, Montréal, Canada
|
|
|
| Plénière IV: |
Innovations in Analgesia |
|
Sergio Ferreira |
|
University of Sao Paulo, Sao Paulo, Brazil
|
|
|
| Plénière V: |
Antioxidants: Disease Prevention, Therapeutic Agents or the Epitome of Uselessness? |
|
Barry Halliwell |
|
Yong Loo Lin School of Medicine National University of Singapore, Singapore
|
|
|
| Plénière VI: |
Malaria Chemotherapy– In Search of Magic Bullets |
|
Stephen A. Ward |
|
Liverpool School of Tropical Medicine, Liverpool, UK
|
|
|
| Plénière VII: |
Prescribing for Pregnant Women: The Facts and the Fears |
|
Laura Magee |
|
British Columbia Research Institute for Children's and Women's Health, Vancouver, Canada
|
|
|
| Plénière VIII: |
Public Health Implications of Research Utilizing Pharmacovigilance Databases |
|
David Clark |
|
University of Otago, Dunedin, New Zealand
|
| Plénière IX: |
Contribution of Pharmacogenomics to Improved Outcome of Drug Therapy: Focus on the Latest Developments
Commandité par la Société canadienne de pharmacologie
|
|
Richard M Weinshilboum |
|
Mayo Clinic College of Medicine, Rochester, USA |
|
|
| Plénière X: |
Future of the Research in Pharmacology |
|
Salvador Moncada |
|
University College London, UK |
